Seeing Is Believing
Currently out of the existing stock ratings of David Saxon, 157 are a BUY (91.28%), 13 are a HOLD (7.56%), 2 are a SELL (1.16%).
Analyst David Saxon, currently employed at NEEDHAM, carries an average stock price target met ratio of 42.34% that have a potential upside of 23.34% achieved within 116 days.
David Saxon’s has documented 329 price targets and ratings displayed on 15 stocks. The coverage is on Technology, Industrials, Healthcare sectors.
Most recent stock forecast was given on GMED, Globus Medical at 07-Nov-2024.
Analyst best performing recommendations are on STAA (STAAR SURGICAL COMPANY).
The best stock recommendation documented was for STAA (STAAR SURGICAL COMPANY) at 8/11/2022. The price target of $110 was fulfilled within 1 day with a profit of $7.97 (7.81%) receiving and performance score of 78.11.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$130
$42.43 (48.45%)
$90
2 years 11 months 26 days ago
(17-Nov-2021)
3/4 (75%)
$10.49 (8.78%)
11
Buy
$150
$62.43 (71.29%)
$145
2 years 11 months 26 days ago
(17-Nov-2021)
8/12 (66.67%)
$30.49 (25.51%)
190
Buy
$149
$61.43 (70.15%)
$113
2 years 11 months 26 days ago
(17-Nov-2021)
7/8 (87.5%)
$29.49 (24.68%)
52
Buy
$155
$67.43 (77.00%)
$139
2 years 11 months 26 days ago
(17-Nov-2021)
1/4 (25%)
$35.49 (29.70%)
45
Buy
$132
$44.43 (50.74%)
$146
2 years 11 months 26 days ago
(17-Nov-2021)
4/6 (66.67%)
$12.49 (10.45%)
208
Which stock is David Saxon is most bullish on?
Which stock is David Saxon is most reserved on?
What Year was the first public recommendation made by David Saxon?